Tue, 03 Feb 2026
The pharmaceutical giant reaffirmed the modest 2026 outlook that rattled investors in December.
>>
Terms of Use | Privacy Policy | Manage Cookies+ | Ad Choices | Accessibility & CC | About | Newsletters | Transcripts
Business News Top © 2024-2025